Submitted by reuters8361 in business
The growth in demand for appetite suppressing anti-obesity drugs like Novo Nordisk's <a href="https://www.reuters.com/markets/companies/NOVOb.CO" target="_blank">(NOVOb.CO)</a> Wegovy presents opportunities for food manufacturers and the market's initially do…